Overview
What is Altius Institute For Biomedical Sciences?
The Altius Institute for Biomedical Sciences is a nonprofit research organization based in Seattle, Washington, with a team of 156 employees. Their primary goal is to advance the field of gene regulation for the betterment of human health. Through their own laboratories and academic collaborations, they conduct extensive research in genetics, genomics, and biotechnology. Their research focuses on gaining a deeper understanding of human cell function in health and disease to develop innovative approaches for diagnosis and therapy. Altius' scientific expertise was leveraged during the pandemic, providing COVID-19 genetic testing services to governmental agencies and local educational organizations, while also conducting research on COVID-19 epidemiology and variants. Their unique scientific discovery environment fosters innovation, enabling scientists to move from ideas to data rapidly.
Official website here: www.altiusinstitute.org
Is Altius Institute For Biomedical Sciences legitimate?
Altius Institute For Biomedical Sciences is a legitimate nonprofit organization registered as a 501(c)(3) entity. Altius Institute For Biomedical Sciences submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $1,360,485
Professional Fundraising Fees: $0
Other Salaries and Wages: $13,949,473
For more financial information, click here
Official website here: www.altiusinstitute.org
What is the mission statement of Altius Institute For Biomedical Sciences?
The Altius Institute for Biomedical Sciences is dedicated to advancing the field of gene regulation for the betterment of human health. Through the use of new technologies and approaches, Altius aims to illuminate cell and tissue functions in both healthy and diseased states. By fostering a scientific discovery environment designed for rapid innovation, Altius enables its scientists to transition from ideas to data more quickly than in any other academic or biotechnology setting. The institute continually strives to translate its data and technology into novel diagnostics, treatments, and strategies for improving human health.
Official website here: www.altiusinstitute.org
Who is the CEO of Altius Institute For Biomedical Sciences?
John Stamatoyannopoulos is the Scientific Director & Treasurer of Altius Institute For Biomedical Sciences.
Official website here: www.altiusinstitute.org
What is the revenue of Altius Institute For Biomedical Sciences?
Altius Institute For Biomedical Sciences's revenue in 2022 was $55,346,565.
Official website here: www.altiusinstitute.org
Who are the executives of Altius Institute For Biomedical Sciences and what are their salaries?
The average compensation at Altius Institute For Biomedical Sciences during 2022 was $98,141. There are 156 employees and 2 volunteers at Altius Institute For Biomedical Sciences.
Here are 11 key members and their salaries:
- John Stamatoyannopoulos (Scientific Director & Treasurer)
- Alister Funnell (Deputy Director)
- Chad Lundberg (Chief Of Staff)
- Michael Cockrill (Chief Technology Officer)
- Jeffrey Vierstra (Principal Investigator)
- Lori Tonnes (General Counsel & Secretary)
- Wouter Meuleman (Principal Investigator)
- Peter Handrinos (Board Member) [Trustee/Director]
- Harry Dietz (Board Member) [Trustee/Director]
- Christopher Miller (Board Member) [Trustee/Director]
- John Lepore (Board Member) [Trustee/Director]
Official website here: www.altiusinstitute.org
Where can I find the form 990 for Altius Institute For Biomedical Sciences?
The Altius Institute For Biomedical Sciences’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.altiusinstitute.org
Learn more at the official website: www.altiusinstitute.org
Mission Statement of Altius Institute For Biomedical Sciences
The Altius Institute for Biomedical Sciences, a pioneering nonprofit organization, is dedicated to propelling the field of gene regulation forward for the betterment of human health. By embracing innovative technologies and approaches, Altius aims to illuminate cell and tissue functions in both health and disease states.
In pursuit of its mission, Altius has established a cutting-edge scientific and technological discovery environment. This unique setting is designed to catalyze groundbreaking innovations, allowing its researchers to swiftly progress from ideas to data, surpassing the capabilities of any other academic or biotechnology setting.
Altius' ultimate objective is to translate its data and technology into novel methods for diagnosing and treating diseases and enhancing human health. This mission is underpinned by its commitment to radical advancements in biomedical discovery, making Altius a trailblazer in the realm of scientific research.
Impact
This information is meant to be a general summary of Altius Institute For Biomedical Sciences. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Altius Institute for Biomedical Sciences is making a significant impact in the field of gene regulation for human health. Through its active and multifaceted program of basic science research in genetics, genomics, and biotechnology, Altius is at the forefront of advancing biomedical discovery. The institute focuses on gaining a deeper understanding of human cell function in both health and disease to develop new approaches for diagnosis and therapy.
Altius is dedicated to developing and translating transformative technologies that enable the control of human genes in medically important contexts. By leveraging diverse technology platforms such as genetic and genomic analyses, cell and genome engineering, single molecule DNA and chromatin analysis, and high-resolution cell imaging, Altius is opening new doors to the discovery of new medicines.
During the pandemic, Altius also demonstrated its commitment to public health by providing COVID-19 genetic testing services under emergency contracts with governmental agencies. This contribution not only helped in testing and research into COVID-19 epidemiology and variants but also showcased Altius' agility and willingness to use its scientific expertise for the greater good.
In essence, Altius Institute for Biomedical Sciences is driving innovation, advancing scientific knowledge, and translating research into tangible benefits for human health, making a profound impact in the field of medical research.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
COVID LAB RESEARCH
Revenue
$12,535,074
COLLABORATE MILESTONE
Revenue
$262,500
Organization Details
Founding Year
2014
Phone
(206) 267-1091
Principal Officer
John Stamatoyannopoulos
Main Address
2211 ELLIOTT AVENUE 600, SEATTLE, WA, 98121
Website
www.altiusinstitute.org
NTEE Category
Code: H00 - Medical research
If you are a representative of Altius Institute For Biomedical Sciences and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.